Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Mendelson

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Addiction Medicine|January 27, 2015
Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot studyReshmi Pal, John E Mendelson, Keith Flower, et al.
The American Journal on Addictions|October 21, 2010
An examination of drug craving over time in abstinent methamphetamine usersGantt P Galloway, Edward G Singleton, Raymond Buscemi, et al.
BMC Clinical Pharmacology|July 23, 2008
The clinical pharmacology of intranasal l-methamphetamineJohn E Mendelson, Dana McGlothlin, Debra S Harris, et al.
Plos One|December 15, 2010
Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humansMatthew J Baggott, Jennifer D Siegrist, Gantt P Galloway, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2016
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled settingMatthew J Baggott, Jeremy R Coyle, Jennifer D Siegrist, et al.
Advances in Pharmacological Sciences|July 13, 2016
MDMA Impairs Response to Water Intake in Healthy VolunteersMatthew J Baggott, Kathleen J Garrison, Jeremy R Coyle, et al.
Psychopharmacology|March 18, 2014
MDMA effects consistent across laboratoriesMatthew G Kirkpatrick, Matthew J Baggott, John E Mendelson, et al.
Journal of Psychoactive Drugs|April 11, 2019
Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy VolunteersMatthew J Baggott, Kathleen J Garrison, Jeremy R Coyle, et al.
Psychopharmacology|December 9, 2010
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trialJohn E Mendelson, Jeremy R Coyle, Juan Carlos Lopez, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Addiction Medicine|January 27, 2015
Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot studyReshmi Pal, John E Mendelson, Keith Flower, et al.
The American Journal on Addictions|October 21, 2010
An examination of drug craving over time in abstinent methamphetamine usersGantt P Galloway, Edward G Singleton, Raymond Buscemi, et al.
BMC Clinical Pharmacology|July 23, 2008
The clinical pharmacology of intranasal l-methamphetamineJohn E Mendelson, Dana McGlothlin, Debra S Harris, et al.
Plos One|December 15, 2010
Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humansMatthew J Baggott, Jennifer D Siegrist, Gantt P Galloway, et al.
Journal of Psychopharmacology (Oxford, England)|February 17, 2016
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled settingMatthew J Baggott, Jeremy R Coyle, Jennifer D Siegrist, et al.
Advances in Pharmacological Sciences|July 13, 2016
MDMA Impairs Response to Water Intake in Healthy VolunteersMatthew J Baggott, Kathleen J Garrison, Jeremy R Coyle, et al.
Psychopharmacology|March 18, 2014
MDMA effects consistent across laboratoriesMatthew G Kirkpatrick, Matthew J Baggott, John E Mendelson, et al.
Journal of Psychoactive Drugs|April 11, 2019
Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy VolunteersMatthew J Baggott, Kathleen J Garrison, Jeremy R Coyle, et al.
Psychopharmacology|December 9, 2010
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trialJohn E Mendelson, Jeremy R Coyle, Juan Carlos Lopez, et al.
Pageof 2